MedTrace Logo

MOVIPREP® Versus PICOLAX® Pilot Study

NCT00312481 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2007-12-17

No results posted yet for this study

Summary

This will be a randomised, single-centre, single-blind, parallel-group, pilot study in patients undergoing colonoscopy.

The primary objective is to evaluate the efficacy of MOVIPREP® versus PICOLAX® for gut cleansing prior to colonoscopy.

The secondary objectives are to evaluate the safety, tolerability and acceptability of MOVIPREP versus PICOLAX for gut cleansing prior to colonoscopy.

Conditions

  • Colonoscopy

Interventions

DRUG

macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate

Split dose, 1-litre solution in the evening prior to colonoscopy and second dose in the morning prior to colonoscopy

DRUG

NA picosulfate magnesium citrate

150 ml solution before 8am on day prior to colonoscopy and 150ml solution 6 to 8 hours later.

Sponsors & Collaborators

Principal Investigators

  • Mike Geraint, MD · Norgine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Completion
2006-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00312481 on ClinicalTrials.gov